🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
Introduction Radiation-induced dermatitis (RID), which includes both acute ...
Status
Enrolling By Invitation
Location
HRAEB
Start Date
2025-09-01
Trial ID
NCT07149506
Open-angle glaucoma is the most common type of glaucoma, a disease that dam...
Status
Not Yet Recruiting
Location
Multiple Locations
Start Date
2026-08-31
Trial ID
NCT07770685
This international, multi-centre, double-blind vaccine study is a three-arm...
Status
Completed
Location
MRC/UVRI and LSHTM Uganda Research Unit
Start Date
2020-12-15
Trial ID
NCT04066881
Treatments Being Tested
The study involves use of isoniazid and cotrimoxazole as strategies for pre...
Status
Completed
Location
Red Cross Childrens Hospital
Start Date
2003-01
Trial ID
NCT00330304
Treatments Being Tested
Cervical cancer is associated with Human Papilloma Virus. About 57% of cerv...
Status
Terminated
Location
New Horizons Women's Care, LLC
Start Date
2010-04
Trial ID
NCT01116245
Treatments Being Tested
This study will test the use of phentermine and topiramate compared with pl...
Status
Withdrawn
Location
University of Minnesota
Start Date
2023-10-17
Trial ID
NCT05834062
Treatments Being Tested
This randomized phase III trial studies ibrutinib to see how well it works ...
Status
Active Not Recruiting
Location
Anchorage Associates in Radiation Medicine
Start Date
2016-10-12
Trial ID
NCT02443077
This study is a randomized, placebo-controlled, double-blind, multicenter p...
Status
Unknown
Location
Multiple Locations
Start Date
2021-01-01
Trial ID
NCT04690283
The purpose of this study is to evaluate the safety, tolerability, and immu...
Status
Completed
Location
Multiple Locations
Start Date
2015-06-15
Trial ID
NCT02416453
Treatments Being Tested
The study is being conducted to evaluate two doses of TEV-48125 in adult pa...
Status
Completed
Location
Teva Investigational Site 13628
Start Date
2016-03-23
Trial ID
NCT02629861
Treatments Being Tested